secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001213900-25-005521
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix settles IQVIA dispute for $150k, records $0.9M reduction in accounts payable
--------------------------------------------------------------------------------

- Resolved IQVIA dispute with $150k payment, avoiding claimed $1.09M liability.
- Mutual release of all claims under the Master Services Agreement; no admission of liability.
- Company to reduce accounts payable by approximately $0.9 million as a result of settlement.
- Proteomedix subsidiary posted on LinkedIn about Proclarix study for clinically significant prostate cancer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025005521/0001213900-25-005521-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025005521/ea0228132-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-005521

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer